Hereditary Retinopathies
Progress in Development of Genetic and Molecular Therapies
Paperback
Lieferzeit: Print on Demand - Lieferbar innerhalb von 3-5 Werktagen I
ISBN-13:
9781461444985
Veröffentl:
2012
Einband:
Paperback
Erscheinungsdatum:
04.08.2012
Seiten:
56
Autor:
Pete Humphries
Gewicht:
102 g
Format:
235x155x4 mm
Serie:
SpringerBriefs in Genetics
Sprache:
Englisch
Beschreibung:
The hereditary retinopathy, retinitis pigmentosa (RP), which affects 1 in 3,500 people worldwide, is the most common cause of registered visual handicap among those of the working age in developed countries. RP is a highly variable disorder where patients may develop symptomatic visual loss in early childhood, while others may remain asymptomatic until mid-adulthood. Most cases of RP segregate in autosomal dominant, recessive or X-linked recessive modes, with approximately 41 genes being implicated in disease pathology to date (RetNet). The extensive genetic heterogeneity associated with autosomal dominant RP (adRP) is an undisputed hindrance to the development of genetically based therapeutics.
Provides a snap-shot of current gene and drug-based therapies for hereditary retinal disorders
Preface.- Introduction.- Gene-based Medicines directly targeting genetic defects and molecular pathologies common to multiple forms of disease.- Molecular Medicines.